Amphastar Gets FDA Approval for Intranasal Naloxone Product
The product was designed using the Amphastar’s proprietary nasal delivery device.
Diagnosis & Disease Information
FDA Limit on Acetaminophen in Combo Opioid Products Linked to Liver Injury Decline
In 2011, following reports of serious livery injury, the FDA had required manufacturers of prescription acetaminophen combination products to limit the amount of acetaminophen to 325mg per tablet or capsule.
RiVive Nasal Spray Gets Priority Review for OTC Treatment of Opioid Overdose
RiVive is an opioid antagonist that reverses the effects of opioids, including respiratory depression, sedation, and hypotension.
FDA Warns of New Social Media Challenge With OTC Cough, Cold Medications
In a recent social media video challenge, individuals were encouraged to cook chicken in NyQuil or another similar OTC cough and cold medication.
Nalmefene HCl Injection Now Available for Opioid Overdose Treatment
Pharmacodynamic studies have shown that nalmefene has a longer duration of action than naloxone.
Gabapentin-Involved Overdose Deaths Increased Between 2019 and 2020
Researchers used data from the State Unintentional Drug Overdose Reporting System in order to assess trends in gabapentin-involved overdose deaths.
FDA Approves Naloxone Auto-Injector as Countermeasure to High Potency Opioids
Naloxone Auto-Injector is specifically designed to be a medical countermeasure for military personnel or chemical incident responders against the potential threat of exposure to synthetic opioids on the battlefield.
HHS Carcinogen Report Updated to Include 8 Substances
The US Department of HHS added 8 new substances to the 15th Report on Carcinogens, bringing the total list to 256 substances.
Intranasal Nalmefene Fast Tracked for Opioid Overdose Treatment
The investigational intranasal formulation of nalmefene demonstrated a more rapid onset and longer duration of action compared with naloxone.
Zimhi Approved for Emergency Treatment of Opioid Overdose
Zimhi is intended for immediate administration as emergency therapy in settings where opioids may be present.
- Loading...
Loading...
Next post in News
Loading... 
Loading...